"Drug Utilization Review" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993.
| Descriptor ID |
D017723
|
| MeSH Number(s) |
N04.452.706.477.400 N04.761.879.300 N05.700.900.300
|
| Concept/Terms |
Drug Utilization Review- Drug Utilization Review
- Evaluation, Drug Utilization
- Drug-Use Review
- Drug Use Review
- Drug-Use Reviews
- Reviews, Drug-Use
- Review, Drug Utilization
- Drug Utilization Reviews
- Reviews, Drug Utilization
- Utilization Reviews, Drug
- Utilization Review, Drug
- Drug Utilization Evaluation
- Drug Utilization Evaluations
- Evaluations, Drug Utilization
- Utilization Evaluation, Drug
- Utilization Evaluations, Drug
- Review, Drug-Use
- Review, Drug Use
|
Below are MeSH descriptors whose meaning is more general than "Drug Utilization Review".
Below are MeSH descriptors whose meaning is more specific than "Drug Utilization Review".
This graph shows the total number of publications written about "Drug Utilization Review" by people in this website by year, and whether "Drug Utilization Review" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Utilization Review" by people in Profiles.
-
Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Aug 21; 2(4):e000214.
-
Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures. Ann Vasc Surg. 2013 Jan; 27(1):62-7.
-
Performance measures for pneumonia: are they valuable, and are process measures adequate? Curr Opin Infect Dis. 2007 Apr; 20(2):182-9.
-
Suboptimal pharmacotherapy in a tribal nursing home. J Am Med Dir Assoc. 2007 Jan; 8(1):1-7.
-
Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs. Ann Pharmacother. 2005 Nov; 39(11):1785-91.